These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27785603)

  • 21. Long non-coding RNA LINC00346 promotes pancreatic cancer growth and gemcitabine resistance by sponging miR-188-3p to derepress BRD4 expression.
    Shi W; Zhang C; Ning Z; Hua Y; Li Y; Chen L; Liu L; Chen Z; Meng Z
    J Exp Clin Cancer Res; 2019 Feb; 38(1):60. PubMed ID: 30728036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miRNA-93-5p Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Targeting the PTEN-Mediated PI3K/Akt Signaling Pathway.
    Wu Y; Xu W; Yang Y; Zhang Z
    Ann Clin Lab Sci; 2021 May; 51(3):310-320. PubMed ID: 34162560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linc-DYNC2H1-4 promotes EMT and CSC phenotypes by acting as a sponge of miR-145 in pancreatic cancer cells.
    Gao Y; Zhang Z; Li K; Gong L; Yang Q; Huang X; Hong C; Ding M; Yang H
    Cell Death Dis; 2017 Jul; 8(7):e2924. PubMed ID: 28703793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The enhancement of Tetrandrine to gemcitabine-resistant PANC-1 cytochemical sensitivity involves the promotion of PI3K/Akt/mTOR-mediated apoptosis and AMPK-regulated autophagy.
    Song J; Xu J; Guo J; Shang Y; Wang J; Wang T
    Acta Histochem; 2021 Sep; 123(6):151769. PubMed ID: 34416437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linc-RNA-RoR acts as a "sponge" against mediation of the differentiation of endometrial cancer stem cells by microRNA-145.
    Zhou X; Gao Q; Wang J; Zhang X; Liu K; Duan Z
    Gynecol Oncol; 2014 May; 133(2):333-9. PubMed ID: 24589415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miRNA-181b increases the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine in vitro and in nude mice by targeting BCL-2.
    Cai B; An Y; Lv N; Chen J; Tu M; Sun J; Wu P; Wei J; Jiang K; Miao Y
    Oncol Rep; 2013 May; 29(5):1769-76. PubMed ID: 23440261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic cancer cells.
    Rajabpour A; Afgar A; Mahmoodzadeh H; Radfar JE; Rajaei F; Teimoori-Toolabi L
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):765-775. PubMed ID: 28887583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-29a induces resistance to gemcitabine through the Wnt/β-catenin signaling pathway in pancreatic cancer cells.
    Nagano H; Tomimaru Y; Eguchi H; Hama N; Wada H; Kawamoto K; Kobayashi S; Mori M; Doki Y
    Int J Oncol; 2013 Oct; 43(4):1066-72. PubMed ID: 23900458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic combination of gemcitabine and dietary molecule induces apoptosis in pancreatic cancer cells and down regulates PKM2 expression.
    Pandita A; Kumar B; Manvati S; Vaishnavi S; Singh SK; Bamezai RN
    PLoS One; 2014; 9(9):e107154. PubMed ID: 25197966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The HIF-2α-MALAT1-miR-216b axis regulates multi-drug resistance of hepatocellular carcinoma cells via modulating autophagy.
    Yuan P; Cao W; Zang Q; Li G; Guo X; Fan J
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1067-73. PubMed ID: 27524242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MGMT expression affects the gemcitabine resistance of pancreatic cancer cells.
    Shi Y; Wang Y; Qian J; Yan X; Han Y; Yao N; Ma J
    Life Sci; 2020 Oct; 259():118148. PubMed ID: 32721465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gemcitabine induces the VMP1-mediated autophagy pathway to promote apoptotic death in human pancreatic cancer cells.
    Pardo R; Lo Ré A; Archange C; Ropolo A; Papademetrio DL; Gonzalez CD; Alvarez EM; Iovanna JL; Vaccaro MI
    Pancreatology; 2010; 10(1):19-26. PubMed ID: 20299819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway.
    Pan Y; Chen J; Tao L; Zhang K; Wang R; Chu X; Chen L
    Oncotarget; 2017 May; 8(20):33144-33158. PubMed ID: 28388536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of PTBP1 in alternative splicing, glycolysis, and oncogensis.
    Zhu W; Zhou BL; Rong LJ; Ye L; Xu HJ; Zhou Y; Yan XJ; Liu WD; Zhu B; Wang L; Jiang XJ; Ren CP
    J Zhejiang Univ Sci B; 2020 Feb.; 21(2):122-136. PubMed ID: 32115910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-216a decreases MALAT1 expression, induces G2/M arrest and apoptosis in pancreatic cancer cells.
    Zhang Y; Tang X; Shi M; Wen C; Shen B
    Biochem Biophys Res Commun; 2017 Feb; 483(2):816-822. PubMed ID: 28034748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MIR210HG regulates glycolysis, cell proliferation, and metastasis of pancreatic cancer cells through miR-125b-5p/HK2/PKM2 axis.
    Yu T; Li G; Wang C; Gong G; Wang L; Li C; Chen Y; Wang X
    RNA Biol; 2021 Dec; 18(12):2513-2530. PubMed ID: 34110962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-137 inhibits autophagy and chemosensitizes pancreatic cancer cells by targeting ATG5.
    Wang ZC; Huang FZ; Xu HB; Sun JC; Wang CF
    Int J Biochem Cell Biol; 2019 Jun; 111():63-71. PubMed ID: 30710750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hsa_circ_0035483 sponges hsa-miR-335 to promote the gemcitabine-resistance of human renal cancer cells by autophagy regulation.
    Yan L; Liu G; Cao H; Zhang H; Shao F
    Biochem Biophys Res Commun; 2019 Oct; 519(1):172-178. PubMed ID: 31492499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circ_0092367 Inhibits EMT and Gemcitabine Resistance in Pancreatic Cancer via Regulating the miR-1206/ESRP1 Axis.
    Yu S; Wang M; Zhang H; Guo X; Qin R
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linc-RoR promotes proliferation, migration, and invasion via the Hippo/YAP pathway in pancreatic cancer cells.
    Chen W; Wang H; Liu Y; Xu W; Ling C; Li Y; Liu J; Chen M; Zhang Y; Chen B; Gong A; Xu M
    J Cell Biochem; 2020 Jan; 121(1):632-641. PubMed ID: 31452251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.